Panacea Biotec Limited
Panacea Biotec Limited, a prominent player in the biopharmaceutical industry, is headquartered in India and operates extensively across various regions, including Europe, Africa, and Asia. Founded in 1984, the company has achieved significant milestones, establishing itself as a leader in the development and manufacturing of vaccines, biopharmaceuticals, and complex generics. Panacea Biotec is renowned for its innovative core products, including a range of vaccines that address critical health challenges, such as hepatitis and polio. The company’s commitment to quality and research-driven solutions sets it apart in a competitive market. With a strong focus on sustainability and social responsibility, Panacea Biotec has garnered recognition for its contributions to public health, solidifying its position as a trusted name in the biopharmaceutical sector.
DitchCarbon Score
How does Panacea Biotec Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Panacea Biotec Limited's score of 0 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Panacea Biotec Limited's reported carbon emissions
Panacea Biotec Limited, headquartered in India, currently does not have available data on its carbon emissions, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions data to analyse. In the absence of concrete emissions data, it is important to note that the company has not outlined any specific reduction targets or commitments to the Science Based Targets initiative (SBTi) or other climate pledges. This lack of publicly available information suggests that Panacea Biotec may still be in the early stages of developing a comprehensive climate strategy or reporting framework. As the pharmaceutical industry increasingly prioritises sustainability and climate action, it will be essential for Panacea Biotec to establish clear emissions reduction goals and transparent reporting practices to align with industry standards and stakeholder expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Panacea Biotec Limited is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
